Type
. Leprosy and tuberculosis: the epidemiological consequences of cross-immunity. American journal of public health [Internet]. 1997;87(12):1923-7. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1381230/pdf/amjph00511-0021.pdf
Type
. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 1997;352(1359):1331-45.
Type
. [Ofloxacin in mycobacteriosis therapy]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 1997;42(11):26-31.
Type
. Rifampin. Annals of internal medicine. 1976;85(1):82-6.
Type
. Human leukocyte antigens in tuberculosis and leprosy. Trends in microbiology. 1998;6(4):148-54.
Type
. [On the lesions caused by a leproma-derived and cultivated Mycobacterium HI-75 produced in ddY mice. With special reference to a factor influencing the lesions and the differences from those by BCG]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 1997;66(3):215-21.
Type
. Infection genomics: Nramp1 as a major determinant of natural resistance to intracellular infections. Annual review of medicine. 1998;49:275-87.
Type
. Understanding the phenomenon of persistence in mycobacterial infections. Indian journal of leprosy. 1997;69(4):385-93.
Type
. IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients. Clinical and experimental immunology [Internet]. 1998;111(1):48-55. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904868/pdf/cei0111-0048.pdf
Type
. Cytokines in infectious diseases. Journal of the Royal College of Physicians of London. 1998;32(3):195-8.